Elias Jabbour

Statistics

Publications

Citations

1.6K

H-Index

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine

Elias Jabbour is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

2005–2024

Publications

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop M. Kantarjian, Susan O’Brien, Elias Jabbour et al. · Blood · 2012 · 338 citations · Full text

Medicine, Hematology, Oncology +5

Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia

Guillermo Garcia‐Manero, Steven D. Gore, Christopher R. Cogle et al. · Journal of Clinical Oncology · 2011 · 250 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia

Claire Roddie, Karamjeet Sandhu, Eleni Tholouli et al. · New England Journal of Medicine · 2024 · 196 citations · Full text

Medicine, Hematology, Oncology +15

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia

Rita Assi, Hagop M. Kantarjian, Nicholas J. Short et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 162 citations

Medicine, Hematology, Oncology +14

Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes

Guillermo Garcia‐Manero, Elias Jabbour, Gautam Borthakur et al. · Journal of Clinical Oncology · 2013 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 20